INFECTION CONTROL IN GENE THERAPY

基因治疗中的感染控制

• 批准号: 6043179
• 负责人: Martin E Evans
• 金额: $ 0.3万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-01 至 2000-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6043179
• 关键词: communicable disease control; gene therapy; meeting /conference /symposium; nosocomial infection control; public health

DESCRIPTION (Applicant's Description) Gene therapy is being studied for the treatment of a wide variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adeno-associated viruses, herpesviruses and others are being engineered to transfer genes into humans. Treatment protocols using recombinant viruses are being introduced into clinical settings. Infection control practitioners will invariably be involved in reviewing the safety of these agents in their clinics and hospitals. To date, no widely available recommendations exist from federal or private organizations to guide infection control practitio- ners. This conference is designed to provide a forum for gene therapy experts to share their perspectives and experiences with infection control practitioners and others who wish to engage in clinical gene therapy protocols. Topics will include, but are not limited to, the management of patient volunteers in the ambulatory and inpatient setting, facility design, safety of healthcare workers, handling of vectors by the pharmacy, housekeeping and disinfection, emergency response to accidents, coordination with outside healthcare facilities including Public Health Departments, and safety for family members and other close contacts. The goals of the conference are to 1) provide a forum where gene therapy experts can gather together to share their perspectives and experience with infection control in gene therapy, and to 2) provide an opportunity for newcomers to the field to learn about issues specific to infection control in gene therapy. The meeting will be held on October 22-23, 1999 at the Marriott Hotel in Lexington, Kentucky.

申请人的描述（Applicant's Description） 基因疗法正在研究用于治疗各种各样的获得性 和遗传性疾病 逆转录病毒，腺病毒，痘病毒， 腺相关病毒、疱疹病毒和其他病毒正在被改造， 把基因转移到人类身上 使用重组病毒的治疗方案是 被引入临床环境。感染控制从业人员将 他们总是参与审查这些药物的安全性， 诊所和医院。 迄今为止，还没有广泛提供的建议 从联邦或私人组织，以指导感染控制预防， 纳斯 本次会议旨在为基因治疗专家提供一个论坛 分享他们在感染控制方面的观点和经验 从业者和其他希望从事临床基因治疗的人 协议. 主题将包括但不限于： 门诊和住院环境中的患者志愿者，设施设计， 卫生保健工作者的安全，药房对病媒的处理， 内务管理和消毒、事故应急响应、协调 与包括公共卫生部门在内的外部医疗机构合作，以及 家庭成员和其他密切接触者的安全。 的目标 会议将1）提供一个基因治疗专家可以聚集的论坛 分享他们在感染控制方面的观点和经验， 基因治疗，2）为该领域的新人提供机会， 了解基因治疗中感染控制的具体问题。 会议 将于1999年10月22日至23日在列克星敦的万豪酒店举行， 肯塔基州。